Daniel Van Plew

2019

In 2019, Daniel Van Plew earned a total compensation of $7.8M as Executive Vice President and General Manager, Industrial Operations and Product Supply at Regeneron Pharmaceuticals, a 13% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$759,266
Option Awards$3,526,669
Salary$683,100
Stock Awards$2,840,008
Other$20,470
Total$7,829,513

Van Plew received $3.5M in option awards, accounting for 45% of the total pay in 2019.

Van Plew also received $759.3K in non-equity incentive plan, $683.1K in salary, $2.8M in stock awards and $20.5K in other compensation.

Rankings

In 2019, Daniel Van Plew's compensation ranked 1,133rd out of 13,971 executives tracked by ExecPay. In other words, Van Plew earned more than 91.9% of executives.

ClassificationRankingPercentile
All
1,133
out of 13,971
92nd
Division
Manufacturing
393
out of 5,701
93rd
Major group
Chemicals And Allied Products
118
out of 2,200
95th
Industry group
Drugs
94
out of 1,886
95th
Industry
Pharmaceutical Preparations
71
out of 1,398
95th
Source: SEC filing on April 24, 2020.

Van Plew's colleagues

We found four more compensation records of executives who worked with Daniel Van Plew at Regeneron Pharmaceuticals in 2019.

2019

Leonard Schleifer

Regeneron Pharmaceuticals

Chief Executive Officer

2019

George Yancopoulos

Regeneron Pharmaceuticals

Chief Scientific Officer

2019

Andrew Murphy

Regeneron Pharmaceuticals

Executive Vice President, Research

2019

Robert Landry

Regeneron Pharmaceuticals

Chief Financial Officer

News

You may also like